For self-injection, the upper arm presents a practical challenge
Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition
For people on GLP-1 medications, the realistic case for NAD+ includes: better mitochondrial support during caloric restriction, reduced cellular energy depletion in muscle tissue, and based on emerging animal research potential support for the gut environment that produces GLP-1 naturally
Providers consider current health status, medication safety, digestive history, family and personal medical history, prior weight loss attempts, and treatment goals before recommending Tirzepatide
Its triple-agonist approach targeting GLP-1, GIP, and glucagon receptors simultaneously has produced the most impressive weight loss results we've seen from any medication: nearly 29% body weight loss in 68 weeks